This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
Volume 6 - The Spring Supplement of Shefaye Khatam 1 -
University Hospital Münster, Neurology Clinic with Institute of Translational Neurology, Albert-Schweitzer-Campus 1, 48149 Münster, Germany , sven.meuth@ukmuenster.de
Abstract: (3100 Views)
Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system associated to myelin loss and neurodegeneration. Clinically patients suffer from diverse symptoms and face the risk to become wheelchair-bound. At the moment MS is incurable, thus there is an unmet need for therapeutic options.
